Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome (Q33856597)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome |
scientific article |
Statements
1 reference
Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome (English)
1 reference
Hagop Kantarjian
1 reference
Zeev Estrov
1 reference
Tapan Kadia
1 reference
Elias Jabbour
1 reference
Gautam Borthakur
1 reference
Sherry Pierce
1 reference
Guillermo Garcia-Manero
1 reference
Sophie Dimicoli
1 reference
Hui Yang
1 reference
Mary Kelly
1 reference
10 November 2011
1 reference
1 reference
87
1 reference
127-129
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference